{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T15:34:11Z","timestamp":1791387251190,"version":"4.3.3"},"reference-count":23,"publisher":"American Medical Association (AMA)","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Neurol"],"published-print":{"date-parts":[[2021,12,1]]},"DOI":"10.1001\/jamaneurol.2021.3828","type":"journal-article","created":{"date-parts":[[2021,10,25]],"date-time":"2021-10-25T15:33:46Z","timestamp":1635176026000},"page":"1454","source":"Crossref","is-referenced-by-count":42,"title":["Left Ventricular Dysfunction Among Patients With Embolic Stroke of Undetermined Source and the Effect of Rivaroxaban vs Aspirin"],"prefix":"10.1001","volume":"78","author":[{"given":"Alexander E.","family":"Merkler","sequence":"first","affiliation":[{"name":"Clinical and Translational Neuroscience Unit, Feil Family Brain and Mind Research Institute, New York, New York"},{"name":"Department of Neurology, Weill Cornell Medical College, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lesly A.","family":"Pearce","sequence":"additional","affiliation":[{"name":"Biostatistics Consultant, St Catharines, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott E.","family":"Kasner","sequence":"additional","affiliation":[{"name":"Department of Neurology, University of Pennsylvania School of Medicine, Philadelphia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashkan","family":"Shoamanesh","sequence":"additional","affiliation":[{"name":"Department of Medicine (Neurology), McMaster University, Population Health Research Institute, Hamilton, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lee A.","family":"Birnbaum","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, University of Texas Health Sciences Center, San Antonio"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hooman","family":"Kamel","sequence":"additional","affiliation":[{"name":"Clinical and Translational Neuroscience Unit, Feil Family Brain and Mind Research Institute, New York, New York"},{"name":"Department of Neurology, Weill Cornell Medical College, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin N.","family":"Sheth","sequence":"additional","affiliation":[{"name":"Department of Neurology, Yale University School of Medicine, New Haven, Connecticut"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richa","family":"Sharma","sequence":"additional","affiliation":[{"name":"Department of Neurology, Yale University School of Medicine, New Haven, Connecticut"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"5","key":"noi210067r1","doi-asserted-by":"publisher","first-page":"e259","DOI":"10.1016\/S2214-109X(13)70089-5","article-title":"Global and regional burden of first-ever ischaemic and haemorrhagic stroke during 1990-2010: findings from the Global Burden of Disease Study 2010.","volume":"1","author":"Krishnamurthi","year":"2013","journal-title":"Lancet Glob Health"},{"issue":"4","key":"noi210067r2","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1161\/STROKEAHA.116.016414","article-title":"Embolic stroke of undetermined source: a systematic review and clinical update.","volume":"48","author":"Hart","year":"2017","journal-title":"Stroke"},{"issue":"4","key":"noi210067r3","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/S1474-4422(13)70310-7","article-title":"Embolic strokes of undetermined source: the case for a new clinical construct.","volume":"13","author":"Hart","year":"2014","journal-title":"Lancet Neurol"},{"issue":"23","key":"noi210067r4","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1056\/NEJMoa1802686","article-title":"Rivaroxaban for stroke prevention after embolic stroke of undetermined source.","volume":"378","author":"Hart","year":"2018","journal-title":"N Engl J Med"},{"issue":"20","key":"noi210067r5","doi-asserted-by":"publisher","first-page":"1906","DOI":"10.1056\/NEJMoa1813959","article-title":"Dabigatran for prevention of stroke after embolic stroke of undetermined source.","volume":"380","author":"Diener","year":"2019","journal-title":"N Engl J Med"},{"issue":"6","key":"noi210067r6","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1161\/STROKEAHA.119.028669","article-title":"Potential embolic sources and outcomes in embolic stroke of undetermined source in the NAVIGATE-ESUS trial.","volume":"51","author":"Ntaios","year":"2020","journal-title":"Stroke"},{"issue":"7","key":"noi210067r7","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1001\/jamaneurol.2019.0591","article-title":"Tailoring the approach to embolic stroke of undetermined source: a review.","volume":"76","author":"Kamel","year":"2019","journal-title":"JAMA Neurol"},{"issue":"1","key":"noi210067r8","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1161\/01.STR.24.1.35","article-title":"Classification of subtype of acute ischemic stroke: definitions for use in a multicenter clinical trial: TOAST trial of org 10172 in acute stroke treatment.","volume":"24","author":"Adams","year":"1993","journal-title":"Stroke"},{"issue":"6","key":"noi210067r9","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1212\/WNL.0000000000003588","article-title":"Left ventricular wall motion abnormalities are associated with stroke recurrence.","volume":"88","author":"Choi","year":"2017","journal-title":"Neurology"},{"issue":"9","key":"noi210067r10","doi-asserted-by":"publisher","first-page":"2434","DOI":"10.1161\/STROKEAHA.117.018263","article-title":"Detection of left ventricular thrombus by cardiac magnetic resonance in embolic stroke of undetermined source.","volume":"48","author":"Takasugi","year":"2017","journal-title":"Stroke"},{"issue":"3","key":"noi210067r11","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1177\/2396987316663049","article-title":"Rivaroxaban for secondary stroke prevention in patients with embolic strokes of undetermined source: design of the NAVIGATE ESUS randomized trial.","volume":"1","author":"Hart","year":"2016","journal-title":"Eur Stroke J"},{"issue":"9","key":"noi210067r12","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.120.007427","article-title":"Left ventricular ejection fraction under continuous-flow mechanical support.","volume":"13","author":"Jain","year":"2020","journal-title":"Circ Heart Fail"},{"issue":"1","key":"noi210067r13","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s13613-019-0526-7","article-title":"Determinants of left ventricular ejection fraction and a novel method to improve its assessment of myocardial contractility.","volume":"9","author":"Monge Garc\u00eda","year":"2019","journal-title":"Ann Intensive Care"},{"issue":"4","key":"noi210067r14","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1111\/jth.2005.3.issue-4","article-title":"Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients.","volume":"3","author":"Schulman","year":"2005","journal-title":"J Thromb Haemost"},{"issue":"5","key":"noi210067r15","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1093\/eurheartj\/ehi485","article-title":"Aspirin plus warfarin compared to aspirin alone after acute coronary syndromes: an updated and comprehensive meta-analysis of 25,307 patients.","volume":"27","author":"Andreotti","year":"2006","journal-title":"Eur Heart J"},{"issue":"4","key":"noi210067r16","doi-asserted-by":"publisher","first-page":"241","DOI":"10.7326\/0003-4819-143-4-200508160-00005","article-title":"Warfarin plus aspirin after myocardial infarction or the acute coronary syndrome: meta-analysis with estimates of risk and benefit.","volume":"143","author":"Rothberg","year":"2005","journal-title":"Ann Intern Med"},{"issue":"9","key":"noi210067r17","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.118.011593","article-title":"Association between left ventricular ejection fraction, wall motion abnormality, and embolic stroke of undetermined source.","volume":"8","author":"Ramasamy","year":"2019","journal-title":"J Am Heart Assoc"},{"issue":"7","key":"noi210067r18","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.1161\/01.STR.0000227121.34717.40","article-title":"Left ventricular systolic dysfunction and the risk of ischemic stroke in a multiethnic population.","volume":"37","author":"Hays","year":"2006","journal-title":"Stroke"},{"issue":"7","key":"noi210067r19","doi-asserted-by":"publisher","first-page":"e364","DOI":"10.1161\/STR.0000000000000375","article-title":"2021 Guideline for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline from the American Heart Association\/American Stroke Association.","volume":"52","author":"Kleindorfer","year":"2021","journal-title":"Stroke"},{"issue":"4","key":"noi210067r20","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1177\/1747493017743062","article-title":"Canadian stroke best practice recommendations: secondary prevention of stroke, sixth edition practice guidelines, update 2017.","volume":"13","author":"Wein","year":"2018","journal-title":"Int J Stroke"},{"issue":"20","key":"noi210067r21","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.1056\/NEJMoa1202299","article-title":"Warfarin and aspirin in patients with heart failure and sinus rhythm.","volume":"366","author":"Homma","year":"2012","journal-title":"N Engl J Med"},{"issue":"17","key":"noi210067r22","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1136\/heartjnl-2018-314381","article-title":"Anticoagulation therapy in heart failure and sinus rhythm: a systematic review and meta-analysis.","volume":"105","author":"Beggs","year":"2019","journal-title":"Heart"},{"key":"noi210067r23","first-page":"k4413","article-title":"Risks and benefits of direct oral anticoagulants versus warfarin in a real world setting: cohort study in primary care.","volume":"363","author":"Vinogradova","year":"2018","journal-title":"BMJ"}],"container-title":["JAMA Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamaneurology\/articlepdf\/2785030\/jamaneurology_merkler_2021_oi_210067_1638811668.34183.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,9]],"date-time":"2021-12-09T16:20:52Z","timestamp":1639066852000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamaneurology\/fullarticle\/2785030"}},"subtitle":["A Subgroup Analysis of the NAVIGATE ESUS Randomized Clinical Trial"],"short-title":[],"issued":{"date-parts":[[2021,12,1]]},"references-count":23,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2021,12,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamaneurol.2021.3828","relation":{},"ISSN":["2168-6149"],"issn-type":[{"value":"2168-6149","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12,1]]}}}